Schedule 3 drug definition

Schedule 3 drug means a Schedule 3 drug within the meaning of the Pharmacy and Drug Act.
Sample 1Sample 2Sample 3
Schedule 3 drug means a schedule 3 drug as set out in section 33(1) of the Pharmacy and Drug Act.
Sample 1

Examples of Schedule 3 drug in a sentence

  • However, travellers travelling for more than three months with more than three months’ supply of a Schedule 3 drug may need a personal import/export licence, while any amount of Schedule 1 drug for any length of travel will require a personal import/export licence.The regime distinguishes between frequent and occasional exporters and has different procedures for the two.

  • It is licensed for children• It belongs to a group of drugs called Benzodiazepines and is a Schedule 3 drug – exempt from safe storage regulations (barbiturates are also Schedule 3).

  • However, the law for this Schedule 3 drug does NOT require safe custody i.e. locked cupboard, nor the need to keep a midazolam controlled drug register.Some institutions are encouraging such practices as part of their own Health and Safety protocols but there is no legal obligation to do so.

  • All drugs subject to the ‘safe storage’ provisions specified in the Misuse of Drugs (Safe Custody) Regulations 1973 (those listed in schedule 1, 2 & certain Schedule 3 drug) shall be securely stored in accordance with those provisions.

Related to Schedule 3 drug

  • Victim or target of Nazi persecution means any individual persecuted or targeted for persecution by

  • Schedule 9 means Schedule 9 to the Taxes Act 1988;

  • Schedule F means internal revenue service schedule F (form 1040) filed by a taxpayer pursuant to the Internal Revenue Code.

  • Federal work authorization program means any of the electronic verification of work authorization programs operated by the United States Department of Homeland Security or any equivalent federal work authorization program operated by the United States Department of Homeland Security to verify information of newly hired employees, pursuant to the Immigration Reform and Control Act of 1986 (IRCA), D.L. 99-603.

  • Regulatory Authorizations means all approvals, clearances, authorizations, registrations, certifications, licenses and permits granted by any Regulatory Authority, including all INDs and NDAs.

  • Disclosed Litigation has the meaning specified in Section 3.01(b).

  • Product Authorizations means any and all approvals, including applicable supplements, amendments, pre- and post-approvals, clearances, licenses, notifications, registrations, certifications or authorizations of any Governmental Authority, any Standard Body necessary for the manufacture, development, distribution, use storage, import, export, transport, promotion, marketing, sale or other commercialization of a Product in any country or jurisdiction.

  • Schedule means a schedule to this Agreement.

  • Public Filings means the reports, schedules, forms, statements and other documents filed by the Company or Bezeq with the SEC or the ISA, as applicable, and publically available at least two (2) Business Days prior to the date of this Agreement.

  • Purchased Intellectual Property has the meaning set forth in Section 1.2(g).

  • Disclosure Schedule means the Disclosure Schedule, dated as of the date hereof, delivered by the Seller to the Purchaser in connection with this Agreement.

  • Company Filings means all documents publicly filed by or on behalf of the Company on SEDAR since January 1, 2020.

  • Prior authorization means that we must approve the Services in advance in order for the Services to be covered.

  • Supplemental Perfection Certificate means a certificate substantially in the form of Exhibit G or any other form approved by the Administrative Agent.

  • SEC Filings has the meaning set forth in Section 4.6.

  • Product Approvals means any approvals, registrations, permits, licenses, consents, authorizations, and other approvals, and pending applications and requests therefor, required by applicable Agencies related to the research, Development, manufacture, distribution, finishing, packaging, marketing, sale, storage or transport of a Product within the United States of America, and includes, without limitation, all approvals, registrations, licenses or authorizations granted in connection with any Application related to that Product.

  • Intellectual Property Licenses means (i) any grant by the Company to another Person of any right, permission, consent or non-assertion relating to or under any of the Purchased Intellectual Property and (ii) any grant by another Person to the Company of any right, permission, consent or non-assertion relating to or under any third Person’s Intellectual Property.

  • Schedule B herein mean Schedule B attached hereto as constituted on the Effective Date, and thereafter as it may be amended from time to time (deemed or in writing) pursuant to Section 16 or 19(l).

  • SEC Documents shall have the meaning specified in Section 4.5.

  • Software Intellectual Property means:

  • Disclosure Schedules means the Disclosure Schedules of the Company delivered concurrently herewith.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Company Licensed Intellectual Property means Intellectual Property Rights owned by any Person (other than a Group Company) that is licensed to any Group Company.

  • Schedule E means internal revenue service schedule E (form 1040) filed by a taxpayer pursuant to the Internal Revenue Code.

  • Licensed Intellectual Property means all Intellectual Property in which the Company holds any rights or interests granted by other Persons, including Seller or any of its Affiliates.

  • Material Related Party Transactions means any transaction/transactions to be entered into individually or taken together with previous transactions during a financial year exceeds 10% of the annual consolidated turnover of the Company as per the last audited financial statements of the Company.